BAD-Glucokinase Axis Regulates Platelet Activation and Thrombosis

Area of Science:

• Hematology
• Molecular Biology
• Cardiovascular Research

Background:

• Bcl2-associated death promoter (BAD) is a proapoptotic protein regulating cell death.
• BAD is expressed in platelets, influencing their lifespan, apoptosis, and clearance.
• The role of BAD in platelet activation and arterial thrombosis is not well understood.

Purpose of the Study:

• To investigate the role of BAD in platelet activation and arterial thrombosis.
• To elucidate the molecular mechanisms by which BAD influences platelet function.
• To explore the potential of the BAD-glucokinase pathway as an antithrombotic target.

Main Methods:

• Utilized BAD-deficient mice and in vitro platelet studies.
• Assessed platelet aggregation, integrin activation, and granule secretion.
• Investigated BAD's effect on platelet energy metabolism and glucokinase activity.
• Employed glucokinase heterozygous knockout mice and a glucokinase activator.

Main Results:

• BAD deficiency prolonged bleeding and arterial occlusion times in mice.
• BAD-deficient platelets showed reduced aggregation, integrin activation, and secretion.
• BAD deficiency decreased platelet glucokinase activity, mitochondrial respiration, and ATP production.
• Glucokinase deficiency phenocopied BAD deficiency, and a glucokinase activator rescued platelet function.

Conclusions:

• The BAD-glucokinase axis is critical for platelet activation and arterial thrombosis.
• Targeting the BAD-glucokinase pathway presents a potential strategy for antithrombotic therapy.